NO2019023I1 - Paclitaxel micellar - Google Patents

Paclitaxel micellar

Info

Publication number: NO2019023I1
Authority: NO; Norway
Prior art keywords: micellar; paclitaxel; paclitaxel micellar
Prior art date: 2007-12-19

Application number

NO2019023C

Other languages

English (en)

Original Assignee

Ardenia Investments Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-19

Filing date

2019-05-08

Publication date

2019-05-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2019023(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-05-08 Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd

2019-05-08 Publication of NO2019023I1 publication Critical patent/NO2019023I1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Transplantation (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO2019023C 2007-12-19 2019-05-08 Paclitaxel micellar NO2019023I1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/SE2007/001127 WO2009078754A1 (en)	2007-12-19	2007-12-19	Drug delivery system for administration of poorly water soluble pharmaceutically active substances
PCT/SE2008/051515 WO2009078802A1 (en)	2007-12-19	2008-12-18	Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (1)

Publication Number	Publication Date
NO2019023I1 true NO2019023I1 (no)	2019-05-08

Family

ID=40795732

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO08861526A NO2231189T3 (no)	2007-12-19	2008-12-18
NO2019023C NO2019023I1 (no)	2007-12-19	2019-05-08	Paclitaxel micellar

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO08861526A NO2231189T3 (no)	2007-12-19	2008-12-18

Country Status (27)

Country	Link
US (4)	US8999382B2 (no)
EP (1)	EP2231189B1 (no)
JP (1)	JP5466172B2 (no)
KR (1)	KR101572703B1 (no)
CN (1)	CN101951956B (no)
AU (1)	AU2008339099B2 (no)
BR (1)	BRPI0821740B1 (no)
CA (1)	CA2709266C (no)
CY (2)	CY1119805T1 (no)
DK (1)	DK2231189T3 (no)
EA (1)	EA015247B1 (no)
ES (1)	ES2650242T3 (no)
FR (1)	FR19C1030I1 (no)
HR (1)	HRP20171796T1 (no)
HU (1)	HUE034684T2 (no)
LT (2)	LT2231189T (no)
LU (1)	LUC00117I2 (no)
MX (1)	MX2010006914A (no)
MY (2)	MY157186A (no)
NL (1)	NL300987I9 (no)
NO (2)	NO2231189T3 (no)
NZ (1)	NZ586859A (no)
PL (1)	PL2231189T3 (no)
PT (1)	PT2231189T (no)
SI (1)	SI2231189T1 (no)
WO (2)	WO2009078754A1 (no)
ZA (1)	ZA201004685B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009078756A1 (en)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) *	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078755A1 (en)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
CA2759332A1 (en) *	2009-04-21	2010-10-28	Selecta Biosciences, Inc.	Immunonanotherapeutics providing a th1-biased response
CN106177940A (zh)	2010-05-26	2016-12-07	西莱克塔生物科技公司	含有佐剂的合成纳米载体的剂量选择
US9994443B2 (en)	2010-11-05	2018-06-12	Selecta Biosciences, Inc.	Modified nicotinic compounds and related methods
CN103908432B (zh) *	2013-01-02	2018-09-21	博瑞生物医药（苏州）股份有限公司	一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112239418B (zh) *	2019-07-18	2023-07-07	上海现代药物制剂工程研究中心有限公司	视黄醇类化合物及其钠盐的制备方法
CN112321465B (zh) *	2019-07-18	2023-06-06	上海现代药物制剂工程研究中心有限公司	一种含苯基化合物、其中间体、制备方法及应用
WO2021259472A1 (en) *	2020-06-24	2021-12-30	Oasmia Pharmaceutical Ab	Micellar docetaxel for use in the treatment of cancer
CN115429886B (zh) *	2021-06-02	2025-10-31	复旦大学	一种药物纳米结晶制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6096331A (en) *	1993-02-22	2000-08-01	Vivorx Pharmaceuticals, Inc.	Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) *	1998-08-31	2002-01-17	Fumapharm Ag Muri	Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) *	1998-12-23	2001-03-06	Ardenia Investments Ltd.	Compounds for the treatment of cancer
US6656504B1 (en) *	1999-09-09	2003-12-02	Elan Pharma International Ltd.	Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) *	2001-05-15	2001-05-15	Ardenia Investments Ltd	Novel potentiating compounds
US20050249786A1 (en) *	2001-09-28	2005-11-10	Solubest Ltd.	Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
US20050191359A1 (en) *	2001-09-28	2005-09-01	Solubest Ltd.	Water soluble nanoparticles and method for their production
SE0202311D0 (sv) *	2002-07-23	2002-07-23	Ardenia Investments Ltd	Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
CN100360502C (zh) *	2002-07-23	2008-01-09	阿登尼亚投资有限公司	视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用
US7259984B2 (en) *	2002-11-26	2007-08-21	Cornell Research Foundation, Inc.	Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja)	2003-09-04	2006-08-03	Nano Career Kk	水溶性の塩基性薬物内包ナノ粒子含有組成物
US20050196343A1 (en)	2004-02-27	2005-09-08	Molecular Therapeutics, Inc.	Degradable nanoparticles
US7871632B2 (en)	2004-07-12	2011-01-18	Adventrx Pharmaceuticals, Inc.	Compositions for delivering highly water soluble drugs
US8945629B2 (en) *	2004-09-10	2015-02-03	University Of Wyoming	Nanoparticles for cytoplasmic drug delivery to cancer cells
AU2006284657B2 (en) *	2005-08-31	2012-07-19	Abraxis Bioscience, Llc	Compositions and methods for preparation of poorly water soluble drugs with increased stability
WO2009078756A1 (en)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) *	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of poorly water soluble pharmaceutically active substances
WO2009078755A1 (en)	2007-12-19	2009-06-25	Ardenia Investments, Ltd.	Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance

2007
- 2007-12-19 WO PCT/SE2007/001127 patent/WO2009078754A1/en not_active Ceased
2008
- 2008-12-18 PT PT88615265T patent/PT2231189T/pt unknown
- 2008-12-18 NO NO08861526A patent/NO2231189T3/no unknown
- 2008-12-18 BR BRPI0821740-8A patent/BRPI0821740B1/pt active IP Right Grant
- 2008-12-18 DK DK08861526.5T patent/DK2231189T3/en active
- 2008-12-18 HR HRP20171796TT patent/HRP20171796T1/hr unknown
- 2008-12-18 SI SI200831891T patent/SI2231189T1/en unknown
- 2008-12-18 NZ NZ586859A patent/NZ586859A/en unknown
- 2008-12-18 HU HUE08861526A patent/HUE034684T2/en unknown
- 2008-12-18 CA CA2709266A patent/CA2709266C/en active Active
- 2008-12-18 KR KR1020107015610A patent/KR101572703B1/ko active Active
- 2008-12-18 EP EP08861526.5A patent/EP2231189B1/en active Active
- 2008-12-18 MY MYPI2010002787A patent/MY157186A/en unknown
- 2008-12-18 MX MX2010006914A patent/MX2010006914A/es active IP Right Grant
- 2008-12-18 AU AU2008339099A patent/AU2008339099B2/en active Active
- 2008-12-18 MY MYPI2010002786A patent/MY157187A/en unknown
- 2008-12-18 LT LTEP08861526.5T patent/LT2231189T/lt unknown
- 2008-12-18 PL PL08861526T patent/PL2231189T3/pl unknown
- 2008-12-18 WO PCT/SE2008/051515 patent/WO2009078802A1/en not_active Ceased
- 2008-12-18 CN CN2008801270180A patent/CN101951956B/zh active Active
- 2008-12-18 ES ES08861526.5T patent/ES2650242T3/es active Active
- 2008-12-18 EA EA200802350A patent/EA015247B1/ru unknown
- 2008-12-18 JP JP2010539385A patent/JP5466172B2/ja active Active
- 2008-12-18 US US12/809,252 patent/US8999382B2/en active Active
2010
- 2010-07-02 ZA ZA2010/04685A patent/ZA201004685B/en unknown
2015
- 2015-02-27 US US14/633,177 patent/US9993438B2/en not_active Ceased
2017
- 2017-12-04 CY CY20171101264T patent/CY1119805T1/el unknown
2019
- 2019-04-24 CY CY2019021C patent/CY2019021I1/el unknown
- 2019-04-25 LT LTPA2019508C patent/LTPA2019508I1/lt unknown
- 2019-05-03 LU LU00117C patent/LUC00117I2/fr unknown
- 2019-05-06 NL NL300987C patent/NL300987I9/nl unknown
- 2019-05-06 FR FR19C1030C patent/FR19C1030I1/fr active Active
- 2019-05-08 NO NO2019023C patent/NO2019023I1/no unknown
2020
- 2020-06-12 US US16/899,848 patent/USRE49741E1/en active Active
2021
- 2021-02-17 US US17/177,550 patent/USRE49742E1/en active Active

Also Published As

Publication number	Publication date
US8999382B2 (en)	2015-04-07
EA015247B1 (ru)	2011-06-30
DK2231189T3 (en)	2017-12-11
HRP20171796T1 (hr)	2018-01-26
US9993438B2 (en)	2018-06-12
MX2010006914A (es)	2010-11-10
AU2008339099B2 (en)	2015-08-13
USRE49742E1 (en)	2023-12-05
AU2008339099A1 (en)	2009-06-25
CA2709266A1 (en)	2009-06-25
EP2231189A4 (en)	2013-10-09
WO2009078802A1 (en)	2009-06-25
CN101951956B (zh)	2012-10-17
CA2709266C (en)	2017-09-26
SI2231189T1 (en)	2018-03-30
LTPA2019508I1 (lt)	2019-05-10
EA200802350A3 (ru)	2009-10-30
HUE034684T2 (en)	2018-02-28
NL300987I9 (nl)	2019-05-16
EA200802350A2 (ru)	2009-06-30
USRE49741E1 (en)	2023-12-05
CN101951956A (zh)	2011-01-19
PL2231189T3 (pl)	2018-03-30
CY2019021I2 (el)	2019-11-27
EP2231189B1 (en)	2017-09-06
NZ586859A (en)	2012-06-29
NL300987I2 (no)	2019-05-09
KR20100094575A (ko)	2010-08-26
KR101572703B1 (ko)	2015-11-27
EP2231189A1 (en)	2010-09-29
LUC00117I2 (no)	2024-05-22
CY1119805T1 (el)	2018-06-27
FR19C1030I1 (fr)	2019-06-21
BRPI0821740A2 (pt)	2020-02-27
MY157187A (en)	2016-05-13
US20150164819A1 (en)	2015-06-18
JP2011507838A (ja)	2011-03-10
BRPI0821740B1 (pt)	2021-05-18
LT2231189T (lt)	2017-12-27
US20110014281A1 (en)	2011-01-20
JP5466172B2 (ja)	2014-04-09
ES2650242T3 (es)	2018-01-17
WO2009078754A1 (en)	2009-06-25
MY157186A (en)	2016-05-13
ZA201004685B (en)	2011-03-30
CY2019021I1 (el)	2019-11-27
PT2231189T (pt)	2017-12-12
NO2231189T3 (no)	2018-02-03

Publication	Publication Date	Title
NO2019023I1 (no)	2019-05-08	Paclitaxel micellar
BRPI0821573A2 (pt)	2016-08-09	benzofuropirimidonas
ATE501136T1 (de)	2011-03-15	Imidazopyridinone
DE502007001207D1 (de)	2009-09-10	Elektrosaugkopf
ATE514696T1 (de)	2011-07-15	Diphenyl-dihydro-imidazopyridinone
DE112008003636A5 (de)	2010-10-21	Mehrzuggruppierer
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI0811451A2 (pt)	2014-11-04	Exopolissacarídeo
BRPI0815547A2 (pt)	2015-02-10	Depsipeptídeos cícliocos
BRPI0812840A2 (pt)	2014-12-09	2-imidazolinas
BRPI0812994A2 (pt)	2014-12-23	Microbiocidas
AT505058A3 (de)	2008-12-15	Türschliesssystem
DE112008001216A5 (de)	2010-02-04	Magnetronplasmaanlage
DE502008001694D1 (de)	2010-12-16	Mitfahrhubwagen
DE112008003094A5 (de)	2010-08-12	Geomatte
DE112008003196A5 (de)	2011-02-03	Handpipettiergerät
DK2162483T3 (da)	2014-08-04	Aminogruppeholdige polyestere
DE112008002200A5 (de)	2010-09-23	Sperrsynchronisiervorrichtung
CU20090155A7 (es)	2011-04-26	Macrolidos
DE502008000815D1 (de)	2010-08-05	Kraftfahrzeugsitzverstellantrieb
DE112008001534A5 (de)	2010-03-18	Anreihgussform
DE102007038931A8 (de)	2009-06-18	Fadenlagennähwirkstoffe
DE602007009636D1 (de)	2010-11-18	Sektionaltor
DE112008002909A5 (de)	2010-07-29	Verwahrbehältnis
DE502007005002D1 (de)	2010-10-21	Durchlaufsägevorrichtung